The phosphorylation sites of the p14fYag-fPs gene product of Fujinami avian sarcoma virus have been identified and localized to different regions of this transforming protein. FSV P140(ag-fps isolated from transformed cells is phosphorylated on at least three distinct tyrosine residues and one serine residue, in addition to minor phosphorylation sites shared with Pr76saS. Partial proteolysis with virion protease p15 or with Staphylococcus aureus V8 protease has been used to generate defined peptide fragments of P140gag-fps and thus to map its phosphorylation sites. The amino-terminal gag-encoded region of P140gag-fps contains a phosphotyrosine residue in addition to normal gag phosphorylation sites. The two major phosphotyrosine residues and the major phosphorserine residue are located in the carboxy-terminal portion of the fps-encoded region of P140gag-fps. pl4gag-fps radiolabeled in vitro in an immune complex kinase reaction is phosphorylated at only one of the two C-terminal tyrosine residues phosphorylated in vivo and weakly phosphorylated at the gag-encoded tyrosine and at a tyrosine site not detectably phosphorylated in vivo. Thus, the in vitro tyrosine phosphorylation of p1409Ja-fPs is distinct from that seen in the transformed cell. A comparative tryptic phosphopeptide analysis of the gag-fps proteins of three Fujinami avian sarcoma virus variants showed that the phosphotyrosine-containing peptides are invariant, and this high degree of sequence conservation suggests that these sites are functionally important or lie within important regions. The P105gag-fps transforming protein of PRCII avian sarcoma virus lacks one of the Cterminal phosphotyrosine sites found in Fujinami avian sarcoma virus P140gag-fps.
The phosphorylation sites of the p14fYag-fPs gene product of Fujinami avian sarcoma virus have been identified and localized to different regions of this transforming protein. FSV P140(ag-fps isolated from transformed cells is phosphorylated on at least three distinct tyrosine residues and one serine residue, in addition to minor phosphorylation sites shared with Pr76saS. Partial proteolysis with virion protease p15 or with Staphylococcus aureus V8 protease has been used to generate defined peptide fragments of P140gag-fps and thus to map its phosphorylation sites. The amino-terminal gag-encoded region of P140gag-fps contains a phosphotyrosine residue in addition to normal gag phosphorylation sites. The two major phosphotyrosine residues and the major phosphorserine residue are located in the carboxy-terminal portion of the fps-encoded region of P140gag-fps. pl4gag-fps radiolabeled in vitro in an immune complex kinase reaction is phosphorylated at only one of the two C-terminal tyrosine residues phosphorylated in vivo and weakly phosphorylated at the gag-encoded tyrosine and at a tyrosine site not detectably phosphorylated in vivo. Thus, the in vitro tyrosine phosphorylation of p1409Ja-fPs is distinct from that seen in the transformed cell. A comparative tryptic phosphopeptide analysis of the gag-fps proteins of three Fujinami avian sarcoma virus variants showed that the phosphotyrosine-containing peptides are invariant, and this high degree of sequence conservation suggests that these sites are functionally important or lie within important regions. The P105gag-fps transforming protein of PRCII avian sarcoma virus lacks one of the Cterminal phosphotyrosine sites found in Fujinami avian sarcoma virus P140gag-fps.
Partial trypsin cleavage of FSV P140gagfPsimmunoprecipitated with anti-gag serum releases C-terminal fragments of 45K and 29K from the immune complex that retain an associated tyrosine-specific protein kinase activity. This observation, and the localization of the major P140gag-fps phosphorylation sites to the Cterminalfps region, indicate that the kinase domain ofp14J9agtfPs is located at its C terminus. The phosphorylation of P140gag-fpS itself is complex, suggesting that it may itself interact with several protein kinases in the transformed cell.
The avian sarcoma viruses (ASVs) are a group of acutely oncogenic RNA tumor viruses. They rapidly induce the neoplastic transformation of cells such as fibroblasts in tissue culture and the formation of sarcomas in animals (4, 10) . Like other transforming RNA tumor viruses, the ASVs have apparently arisen by recombination between a cellular gene and a nontransforming, replication-competent viral genome, usually resulting in the deletion of viral replicative coding sequences and their substitution by the transduced cellular sequence (23, 37) . The proteins encoded by the cellularly derived transforming genes of these viruses are directly responsible for the initiation and maintenance of the transformed phenotype of infected cells (4, 10) . Among the ASVs, four distinct transforming genes have been identified: src (Rous sarcoma virus),fps (Fujinami avian sarcoma virus [FSV] , PRCII), yes (Y-73), and ros (UR2) (15, 17, 18, 37, 39, 43, 44) . The amino acid sequences of their gene products, predicted from DNA sequence data, show remarkable homology in their carboxy-terminal 300 amino acids, whereas their amino termini are largely unrelated (17, 36) . Reflecting this structural relationship, the ASV transforming proteins are all associated with protein kinase activities specific for tyrosine residues and are themselves phosphorylated at both serine and tyrosine sites (11, 12a, 13, 24, 29, 30, 35) . Cells transformed by these viruses show elevated levels of phosphotyrosine resulting from the phosphorylation of a number of cellular proteins (9, 20, 30, 35) . The sets of cellular proteins phosphorylated at tyrosine in response to transformation by the different classes of ASV show considerable overlap, and although a few have been identified (6, 22, 27, 34 ) the function of most of these cellular targets and the relationship between their phosphorylation and the phenotypic changes seen in transformed cells is unclear. Variants of FSV and Rous sarcoma virus which induce a temperature-sensitive transformed cell phenotype are also temperature sensitive for the phosphorylation of cellular proteins (14, 30, 35) , and temperature-sensitive FSV (tsFSV) encodes a transforming protein that rapidly loses its kinase activity and undergoes dephosphorylation of its tyrosine and serine residues at the nonpermissive temperature (30) . Transformation-defective mutants of Snyder-Theilen feline sarcoma virus, which is closely related to FSV (2, 38) , are deficient in protein kinase activity (3) . These data have suggested that the ASV transforming proteins induce cellular transformation by modulating the control of cell growth, structure, and gene expression through the pleiotropic effect of protein phosphorylation.
The 4.5-kilobase genomic FSV RNA encodes a 140 to 150K protein (p140gag-fPs) synthesized from a defective gag gene and the fps gene (15, 18) . The nondefective gag gene of a replicationcompetent virus encodes a precursor (Pr76gag) to the five virion core proteins (40) . We have previously shown that P140gag-fps possesses an N-terminal sequence of approximately 40K corresponding to the gag proteins p19, plO, and part of p27 and a C-terminal sequence of 100 to 110K synthesized from the fps gene (31) . FSV P140gag-fps immunoprecipitated with antiserum directed against antigenic determinants in its gag orfps regions is itself phosphorylated exclusively at tyrosine residues after incubation in vitro with [y-32P]ATP and Mn2+ (12, 21, 31) . In contrast, P140gag-fps isolated from transformed cells is phosphorylated at both serine and tyrosine residues, of which the major sites are found in the fps-encoded region (12, 30, 31 (15, 18, 30) . Temperature-sensitive tsFSV clone L5 and its temperatureresistant derivative, trFSV, were both pseudotyped with FSV-associated helper virus (FAV) and encode a 140K protein (P140Wa9-fPs) (30) . FSV clone 12 encodes a 130K protein (P1309a9-fPs) and comes from a different FSV stock (14, 15) . PRCII rescued with ring-neck pheasant virus was obtained from G. S. Martin. gschicken embryo fibroblasts (CEFs) were obtained from H & N Farms, and Japanese quail embryo fibroblasts were obtained from the quail unit, University of British Columbia. Cells were infected with virus (5 x 107 to 1 x 108 focus-forming units per ml), passaged after 3 or 4 days, and used on the day 4 or 5. Unless otherwise specified, all cells were maintained at 370C.
Radiolabeling of cells. Cells were seeded at a density of 2 x 105 cells in a 10-mm well (Linbro) and the following day were incubated wtih 32Pi (2.0 mCi/ml, carrier free; ICN Pharmaceuticals, Inc.) in 0.5 ml of phosphate-free Dulbecco modified Eagle medium containing 1% calf serum and 1% heat-inactivated chicken serum. After the labeling period the dish was transferred to ice, and the cells were washed two times with ice-cold phosphate-buffered saline and then lysed in a total of 750 ,ul of lysis buffer (1% Nonidet P- 40 Tris-hydrochloride (pH 7.5) at 20°C as described previously (30) . After the incubation the immunoprecipitate was washed as described previously (30) , except that the buffers contained 10 mM ATP and 10 mM EDTA, and prepared for gel electrophoresis. SDS-polyacrylamide gel electrophoresis. Samples were heated at 100°C for 3 min in SDS sample buffer (2% SDS, 5% ,-mercaptoethanol, 10 mM Tris-hydrochloride [pH 6.8], 10% [vol/vol] glycerol), and then subjected to electrophoresis through SDS-polyacryl-amide slab gels at 3 W per gel. Separating gels usually contained 7.5% acrylamide cross-linked with 0.2% bisacrylamide. Gels used for V8 protease digestion and separation of the resulting cleavage products were as described by Cleveland et al. (7), with separating gels of 15% acrylamide cross-linked with 0.0867% bisacrylamide. After electrophoresis, gels of 32P-labeled proteins were either covered with Saran Wrap and exposed to film (Kodak XAR-5) while wet at 4°C or stained with Coomassie blue to locate molecular weight markers of known size. Fixed and stained gels were dried, and the sensitivity of detection of 32p was increased by using an intensifying screen (DuPont; Lightning-Plus) with XAR-5 film at -80°C. Gels of
[35S]methionine-labeled proteins were impregnated with En3Hance (New England Nuclear Corp.) before drying and exposed at -80°C, unless the proteins were to be analyzed further, in which case fluorography was omitted.
Partial proteolytic cleavage with p15, V8 protease, and trypsin. Immunoprecipitates of gag-related proteins were incubated with NP40-disrupted virions (Prague B Rous sarcoma virus) as described previously (31, 41) . For the cleavage of proteins phosphorylated in vitro, 10 mM ATP and 10 mM EDTA were included in all buffers after the termination of the kinase reaction.
Limited proteolysis with V8 protease was performed in situ in SDS-polyacrylamide gels as described by Cleveland et al. (7) . Proteins were labeled wtih 32p in vivo or in vitro and purified after immunoprecipitation by SDS-polyacrylamide gel electrophoresis. The pertinent bands were excised from wet gels, equilibrated with buffer (125 mM Tris-hydrochloride [pH 6.8], 1 mM EDTA, 0.1% SDS), and applied to the sample well of a fresh gel with a 5-cm-long stacking gel and a 15% polyacrylamide separating gel. The sample was overlaid, first with this buffer containing 20% glycerol and then with buffer containing 10%o glycerol and V8 protease. Electrophoresis was performed at 2 W until the dye front approached the separating gel, when the current and the cooling system were turned off for 30 min. Electrophoresis was then resumed at 3 W. Limited proteolysis with trypsin of immunoprecipitated proteins was performed essentially as described previously (33) . Cells were lysed and immunoprecipitated as described above. The immune complex adsorbed to S. aureus was washed with three immunoprecipitation buffers as described above, suspended in 30 ,ul of pH 9 buffer (10 mM Tris-hydrochloride [pH 9], 100 mM NaCl, 5 mM KCI, 1 mM CaCl2, 0.5 mM MgCl2, 0.5% NP40 [33] ), and incubated with 30 p.g of tolylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin on ice for 15 or 30 min.
To perform protein kinase reactions after 15 minutes of partial trypsin cleavage, the pH was adjusted to 7.5, and MnCl2 was added to a final concentration of 10 mM in the presence of 5 ,uCi of [_y-32P]ATP, and the incubation was continued for 15 minutes on ice. Alternatively, the immune complex was pelleted by centrifugation after trypsin digestion and suspended in 30 ,ul of 10 mM MnClI-20 mM Tris-hydrochloride (pH 7.5), whereas the supernatant from the centrifugation was made to pH 7.5 and 10 mM MnCl2. Both incubations were continued on ice in the presence of [,y-32P]ATP.
Reactions were terminated by the addition of SDS-gel sample buffer.
Analysis of tryptic peptides and phosphoamino acids. 32P-labeled proteins were purified by SDS-polyacrylamide gel electrophoresis, eluted from the gel slices, oxidized, and digested with TPCK-treated trypsin as described previously (30, 31) . Tryptic digests were separated in two dimensions on 20-by 20-cm thinlayer cellulose plates (0.1 mm; E. Merck Labs) using electrophoresis at pH 2.1 (water-88% formic acidacetic acid, 90:2:8 by volume) for 60 min at 1,000 V in the first dimension and chromatography in N-butanolacetic acid-water-pyridine (75:15:60:50, by volume) in the second dimension. 32p was detected by exposing the plates to XAR-5 ifim at -80°C with the aid of an intensifying screen.
[35S]methionine-labeled proteins were eluted from gel slices from a preparative gel, oxidized, digested with TPCK-trypsin and analyzed as for 32P-labeled proteins (30) . Thin-layer cellulose plates were sprayed with En3Hance and exposed to film at -80°C.
Phosphoamino acids obtained by hydrolysis of 32p-labeled proteins or isolated tryptic phosphopeptides in 6 N HCI at 110°C for 90 min in vacuo were identified as described previously after electrophoresis on thinlayer cellulose plates at pH 1.9 and pH 3.5 (30, 35) . Phosphotyrosine for use as a marker was a generous gift of B. Sefton.
Cell-free translation. Isolation of polyadenylated, heat-denatured FSV(FAV) 70S virion RNA and its translation in the messenger-dependent rabbit reticulocyte lysate was as described previously (18, 30 (Fig. 1C ) after electrophoresis at pH 2.1 and chromatography in a butanolacetic acid-pyridine buffer on a thin-layer cellulose sheet. Under some conditions of analysis spots 3a and 3b were not seen, and 3c was the major phosphorylated peptide. Reanalysis of purified peptide 3c under the experimental conditions used in Fig. 1 generated peptides 3a and 3b, suggesting that these are derived by modification of peptide 3c, and that spots 3a through c represent different forms of the same tryptic peptide (data not shown). In contrast, the relatively minor tryptic phosphopeptides 1 phosphorylation (see below), suggesting that P140 is phosphorylated in vitro at three different tyrosine residues.
To compare the P140 sites phosphorylated in vitro by its associated kinase activity with the residues actually phosphorylated in the transformed cell, P140 was isolated from 32P-labeled tsFSV L5-transformed chicken embryo fibroblasts and subjected to tryptic phosphopeptide analysis ( Fig. 1A and B ). P140 labeled in vivo yields five major phosphotyrosine-containing spots when analyzed in this way, of which four (peptides 1 For in vivo-phosphorylated P140 the relative labeling of the tyrosine residues within tryptic phosphopeptides 1, 4, and 3a through c is approximately 0.2:0.6:1 (where the figure for 3a through c is the sum of these spots), although it is hard to know whether this reflects the actual steady-state levels in vivo. On in vitro-phosphorylated P140, spots 3a through c represent a single major site of tyrosine phosphorylation, with tryptic phosphopeptides 1 Fig. 7 ). The cleavage of P140 by the avian retrovirus virion protease p15 has been previously described (31, 41, 42) .
p15 cuts P140 within its N-terminal gag region, yielding a 33K, N-terminal, gag-encoded fragment [N-33K(pl5)] and a C-terminal, 120K fragment [C-120K(pl5)] that contains a small region of gag p27 sequence and the entire C-terminal fps-encoded region (31) . To localize phosphorylation sites to these two fragments, P140 was labeled in vivo with 32p or phosphorylated in vitro in the immune complex reaction and then cleaved with p15 by the addition of disrupted Rous sarcoma virus virions to the immunoprecipitated protein. Figure 2 shows that both the N-33K(p15) and the C-120K(plS) fragments of in vivo-and in vitro-phosphorylated P140 are labeled with 32p. Phosphoamino acid analysis of the N-terminal 33K fragment of in vitro-phosphorylated P140 revealed only phosphotyrosine, whereas the corresponding 33K fragment from P140 phosphorylated in transformed cells contained phosphoserine and phosphotyrosine in equivalent amounts (data not shown). Tryptic phosphopeptide analysis of the N-terminal 33K gag fragment of P140 phosphorylated in vivo yielded the acidic phosphotyrosine-containing tryptic peptide 1 in addition to phosphopeptides which comigrate with those of FAV Pr76gag (Fig. 3A) . The N-33K(p15) fragment of in vitrophosphorylated P140 is labeled only at tryptic phosphopeptide 1 (Fig. 3B ). The C-terminal 120K p15 cleavage fragment of in vivo-phosphorylated P140 gives phosphotyrosine-containing tryptic peptides 3a through c and 4 and phosphoserine-containing peptide 5 ( Fig. 3D) , whereas the C-120K(p15) fragment of P140 labeled in the immune complex reaction contains only peptides 3a through c (Fig. 3E) . These results indicate that P140 is phosphorylated in transformed cells at a tyrosine site (tryptic phosphopeptide 1) within the gag region in addition to sites of phosphorylation shared with nondefective Pr76gag. However, the major sites of tyrosine (peptides 3a through c and 4) and serine (peptide 5) 120K(p15) more accurately within the fps-encoded region of FSV P140 we generated partial proteolytic cleavage fragments with S. aureus V8 protease (17) by the technique of Cleveland et al. (7) . Digestion of 32P-labeled P140 with low concentrations of V8 protease yields two major products with apparent molecular weights of 78K and 61K [78K(V8) and 61K(V8)] (Fig. 4) 5 ) showed that the 78K(V8) fragment contains all of the tryptic peptides previously identified as gag specific, whereas the 61K(V8) fragment contains only tryptic peptides previously identified as fps specific (31) (Fig. 3) . In particular, there is no apparent overlap between these two V8 protease cleavage fragments, arguing that they represent a unique N-terminal 78K fragment and a unique C-terminal 61K fragment presumably separated at a single V8 protease cleavage site in the middle of the P140 fps region. To test this deduction, we isolated the C-120K(p15) fragment of in vitro-phosphorylated during an immune complex kinase reaction, purified by SDS-polyacrylamide gel electrophoresis, and then subjected to in situ digestion with V8 protease in a new gel with a 15% polyacrylamide separating gel; A, 500 ng of V8 protease; B, 100 ng of V8 protease; C, 50 ng of V8 protease.
P140 and digested it with V8 protease (Fig. 6) ; this generated the same 61K(V8) fragment as is contained within intact P140, but no 78K(V8) fragment. This would be expected if 78K(V8) corresponded to the N-terminal half of P140 and 61K(V8) to its C-terminal half since C-120K(pl5) has lost most of the gag sequence but retains all of the C-terminal fps sequence. The N-terminal 33K(pl5) fragment is resistant to limited V8 protease digestion. Tryptic phosphopeptide analysis of the Nterminal 78K and C-terminal 61K V8 protease fragments [N-78K(V8) and C-61K(V8)] of P140 from 32P-labeled tsFSV L5-transformed cells showed that the C-61K(V8) fragment contains peptides 3a through c, 4, and 5, whereas the N-78K(V8) fragment contains peptide 1 (Fig. 5 ). This concurs with the localization of phosphotyrosine-containing tryptic peptide 1 to the Nterminal gag region and shows that the two major phosphotyrosine sites (peptides 3a through c and 4) and the major phosphoserine site (peptide 5) are clustered C terminally in the P140 fps region. A similar analysis of P140 phosphorylated in vitro in the immune complex kinase reaction (Fig. 5) demonstrates that N-78K(V8) contains tryptic phosphopeptides 1 and 2, whereas C-61K(V8) contains only tryptic phosphopeptides 3a through c. This is consistent with our observation that the N-78K(V8) from in vitro-phosphorylated P140 is more heavily labeled with 32P relative to C-61K(V8) than the corresponding fragment from in vivo-phosphorylated P140 (data not shown). It is possible that in vitro-phosphorylated peptide 2 is near the site of p15 cleavage, since it is not easily recovered in the p15 cleavage fragments.
The results of these mapping experiments are shown diagramatically in Fig. 7 .
Phosphorylation of the transforming proteins of different4s viruses. FSV L5 induces a temperature-sensitive, transformed phenotype and encodes a P140 with a thermolabile protein kinase activity (30) . To determine whether this temperature sensitivity reflects any change in the amino acid sequences immediately surrounding the P140 phosphorylation sites, we analyzed the tryptic phosphopeptides of its temperature-resistant derivative, trFSV. Figure 8 shows that trFSV and tsFSV P140 isolated from 32P-la- the N-terminal end of fps. PI phosphorylated in the immune reaction has a tryptic phosphope tical to that of in vitro-phosphor and tsFSV P140, showing tha sequences coding for the con phosphorylation sites 1 and 3a ti P105 phosphorylated in vivo is l phosphopeptides 1 and 3a throu very weakly at the phosphotyrc sented by tryptic phosphopeptic FSV transforming proteins exam fore possible that this site is cot region of FSV P140 that is de P105.
Kinase activity of FSV P140W deavage fragments. We have use cleavage of FSV P140 to genera ments which retain protein kinal P140 was immunoprecipitated v rum, labeled in the immune co0 washed extensively, and then with trypsin for 15 or 30 min. The S. aureusassociated immune complex was then pelleted by centrifugation, and the P140 trypsin cleavage -'.-120K fragments remaining bound in the immune complex were compared with those released from the complex and left in the supematant (Fig. 9) . No intact P140 was seen after 15 min of partial tryptic digestion, but 32P-labeled fragments of 45K, 36K, 29K, and 23K were generated (Fig. 9 , lanes G through J). All four fragments were found in the immune complex after digestion t-33K (Fig. 9, lanes G and I) , but only the 45K and 29K fragments were released from the complex (Fig.  9 , lanes H and J specific protein kinase domain of P140 is contained within a C-terminal 45K fragment that can be released from the immune complex by partial trypsin cleavage. At least one of the major tyrosine phosphorylation sites, represented by tryptic phosphopeptides 3a through c, is contained within this fragment, and this C-terminal location of the kinase domain is consistent with the C-terminal clustering of the major fps phosphorylation sites.
DISCUSSION
Our data show that FSV P140 is phosphorylated in transformed cells at multiple tyrosine residues, and comparative tryptic phosphopeptide analysis indicates that these residues lie within sequences that are highly conserved between the transforming proteins of different FSV variants. As previously reported (31) , the N-terminal gag region of P140 contains minor phosphor- ylation sites shared with Pr76gag, but surprisingly is also phosphorylated at a tyrosine residue contained within an acidic tryptic phosphopeptide. The importance of the gag phosphotyrosine site, and indeed of the fps phosphorylation sites, to the functional activity of the protein remains to be seen. Clearly, the tyrosine phosphorylation within the gag region is specific, but whether this represents fortuitous phosphorylation owing to the proximity of this sequence to a kinase active site or an important functional modification is unknown. The major fps-specific phosphorylation sites of FSV P140, including two phosphotyrosine residues and a phosphoserine residue, are clustered C terminally in thefps region, as represented by the 61K Cterminal V8 protease fragment. We have found that C-terminal fragments released from P140 by partial trypsin cleavage retain the protein kinase activity of P140 and must therefore contain the kinase domain. RSV pp6(Yrc also yields a Cterminal fragment with kinase activity (19) , indicating a functional homology between the Cterminal domains of these two ASV transforming proteins. The C-terminal localization of the major fps phosphorylation sites and the detection of trypsin fragments with kinase activity support the suggestion that the C-terminal sequences of the ASV transforming proteins are highly conserved because they encode the kinase domain. The conservation of sequence surrounding the P140 phosphotyrosine residues argues that these sites are important for the activity of the protein, although the relationship between the phosphorylation of P140 itself and its kinase activity is not yet clear. The extensive phosphorylation of FSV P140gag-fps is in contrast to RSV pp6(Yrc, which is reported to contain only two phosphorylation sites-an N-terminal phosphoserine and a C-terminal phosphotyrosine (8, 35) . Several groups have compared the phosphotyrosine sites from a number of different virus transforming proteins and cell proteins by using microsequencing (25, 26, 28) . There is substantial homology between the characteristically acidic amino acid sequences N terminal to the tyrosine phosphorylation sites. For PRCII P105gag-fps and FSV P140gag-fps phosphorylated in vitro, the major tyrosine phosphorylation site has a glutamic acid four residues N terminal to the phosphotyrosine and a basic amino acid seven residues N terminal (28) . Examination of the amino acid sequence of FSV P130ga-fPs deduced from DNA sequence data shows a tyrosine at residue 1,073 from the N terminus of the 1,182-residue protein fulfilling these characteristics (36) . The N-terminal amino acid of the tryptic peptide containing this sequence is glutamine, as initially suggested to account for poor yields in microsequencing (26) . Cyclization of this glutamine residue after hydrolysis of its side chain amide group during the tryptic mapping procedure yields a more negatively charged species at pH 2.1. These observations suggest that tryptic peptides 3a through c, which we find as the major tyrosine phosphorylation site in vitro, correspond to this peptide.
P140 is also phosphorylated in vivo at a Cterminal tyrosine residue contained within peptide 4. It is intriguing that this residue is not phosphorylated in the immune complex kinase reaction, whereas a tyrosine residue in the N-VOL. 46, 1983 on June 29, 2017 by guest http://jvi.asm.org/ Downloaded from terminal region of the protein (peptide 2) is labeled in vitro, but not in vivo. Tryptic phosphopeptide 4 is also apparently absent from digests of PRCII P105 and is thus distinguished on these two counts from peptides 1 and 3a through c. The absence of this tyrosine phosphorylation site in PRCII P105 clearly does not limit its kinase activity, although whether it has anything to do with the decreased oncogenicity of PRCII (5) remains to be seen. These data raise the possibility that more than one kinase is involved in the phosphorylation of P140 tyrosine residues in transformed cells. Since the amino acid sequence of FSV P130ag-fPs is available, it will be possible to define the exact residues phosphorylated. A more detailed investigation of existing mutants and the construction of sitespecific mutants will be required to reveal the relationship between the phosphorylation of FSV P140 and its enzymatic and transforming activities. The 98K product of the c-fps gene is reported to possess in vitro tyrosine-specific kinase activity, but to lack phosphotyrosine itself (21) . It will be interesting to compare the yeptide sequences and kinase domains of p98c
JPs and p14(gag-fps.
